Want to see FR:EMEIS full AI Analyst Report?
EMEIS Stock Chart & Stats
€13.08
-€0.05(-0.36%)
At close: 4:00 PM EDT
€13.08
-€0.05(-0.36%)
Day’s Range― - ―
52-Week Range€11.77 - €16.19
Previous CloseN/A
Volume223.98K
Average Volume (3M)162.60K
Market Cap
€2.00B
Enterprise Value€10.44K
Total Cash (Recent Filing)€337.00M
Total Debt (Recent Filing)€8.02B
Price to Earnings (P/E)―
Beta0.90
Next Earnings
May 07, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.84%
Share Statistics
EPS (TTM)-1.64
Shares Outstanding161,440,050
10 Day Avg. Volume110,187
30 Day Avg. Volume162,597
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.64
Price to Sales (P/S)0.39
P/FCF Ratio4.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.71
Revenue Forecast (FY)€6.07B
Bulls Say, Bears Say
Bulls Say
Occupancy And Revenue GrowthImproving occupancy and pricing are central drivers of Emeis’s facility-based revenue model. Sustained gains indicate better utilization of its existing network, supporting organic growth and operating leverage without relying solely on acquisitions or asset disposals.
Margin ExpansionStrong EBITDA and margin improvement shows that operational recovery is translating into better earnings before financing costs. If productivity measures and occupancy gains persist, the company can build a more durable profitability base and improve cash generation.
Deleveraging ProgressMaterial debt reduction and lower leverage improve financial resilience compared with the prior year. The remaining cash balance and largely fixed or hedged debt provide additional funding visibility while management continues working toward lower leverage and covenant compliance.
Bears Say
High LeverageDespite recent deleveraging, the absolute debt burden remains substantial relative to earnings. This limits financial flexibility, keeps covenant reduction a multi-year priority, and leaves the business more exposed to financing costs or weaker operating performance.
Persistent Net LossesThe continued net loss means operational improvement has not yet translated into full bottom-line profitability. Until earnings become consistently positive, retained capital generation remains constrained and confidence in the durability of the recovery is lower.
Cash Conversion PressureCash generation is being reduced by normalization payments, working-capital absorption, and higher maintenance investment. These demands can slow debt reduction and limit the amount of internally generated cash available for operations, reinvestment, or balance-sheet repair.
Orpea SA News
EMEIS FAQ
What was Orpea SA’s price range in the past 12 months?
Orpea SA lowest stock price was €11.77 and its highest was €16.19 in the past 12 months.
What is Orpea SA’s market cap?
Orpea SA’s market cap is €2.00B.
When is Orpea SA’s upcoming earnings report date?
Orpea SA’s upcoming earnings report date is May 07, 2027 which is in 230 days.
How were Orpea SA’s earnings last quarter?
Orpea SA released its earnings results on Jul 29, 2026. The company reported -€0.25 earnings per share for the quarter.
Is Orpea SA overvalued?
According to Wall Street analysts Orpea SA’s price is currently Overvalued.
Does Orpea SA pay dividends?
Orpea SA pays a Notavailable dividend of €57.478 which represents an annual dividend yield of 0.84%. See more information on Orpea SA dividends here
What is Orpea SA’s EPS estimate?
Orpea SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orpea SA have?
Orpea SA has 161,440,050 shares outstanding.
What happened to Orpea SA’s price movement after its last earnings report?
Orpea SA reported an EPS of -€0.25 in its last earnings report. Following the earnings report the stock price went up 2.353%.
Which hedge fund is a major shareholder of Orpea SA?
Currently, no hedge funds are holding shares in FR:EMEIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Orpea SA
Emeis Société anonyme operates as a prominent provider of diverse healthcare services, encompassing the management of nursing homes, assisted-living facilities, specialized post-acute and rehabilitation hospitals, and psychiatric treatment centers. Within its elderly care residences, the company delivers tailored support alongside comprehensive logistical and residential amenities, including comfortable accommodation, meal services, laundry, and room maintenance. These facilities also enrich residents' lives with a variety of daily events, recreational activities, and therapeutic workshops. Emeis's post-acute and rehabilitation hospitals are equipped to treat a wide array of medical conditions, such as geriatric issues, musculoskeletal and neurological disorders, cardiovascular and hematological ailments, oncology recovery, and care for individuals in persistent vegetative or minimally conscious states. The psychiatric hospitals address an extensive spectrum of mental health concerns, ranging from mood, anxiety, and obsessive-compulsive disorders to addictions, eating disorders, sleep disturbances, personality disorders, age-related psychiatric conditions, psychosis, and stress-induced conditions like burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic issues, and post-traumatic stress disorder. Furthermore, they offer specialized psychiatric care for geriatrics, children, young adults, and parent-child dynamics, serving both public and private patients. Complementing its institutional offerings, Emeis also provides comprehensive home care solutions. These include practical domestic assistance such as cleaning, meal preparation, ironing, gardening, and running errands; daily living support encompassing day or night supervision and aid with hygiene and meals; and mobility assistance. Founded in 1989 and headquartered in Puteaux, France, the company maintains an expansive international presence, with operations spanning numerous countries across Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China.
Technical Analysis
Eurofins Scientific
―
Clariane
―
LNA Sante SA
―
Equasens
―
Ramsay Generale de Sante
―




